11/15/2009 Sunday, November 15, 2009 (Irvine, California) Today StockRing.com Recommendation is to "SUPER BUY"for ALLERGAN INC (NYSE:AGN) Stock.
AGN stock opening price was $59.24 per share.
Current price of NYSE:AGN Stock is $59.63 per share
and it is
$+0.16, (+0.27%) today
and it was trading in the daily range of $59.1656 - 59.92 per share.
Current Bid Price for (NYSE:AGN) stock is $58.90 and the Ask Price is $60.56. In the last 52 weeks
AGN stock was trading in the range of $28.95 - 60.85. 50-Day Moving Average for (NYSE:AGN) stock is
$57.2587 and 200-Day Moving Average is $51.852. On average analysts predict that One Year Target Estimated price for
(NYSE:AGN) stock is $65.04.
ALLERGAN INC (NYSE:AGN)Market capitalization is $18.098B. (NYSE:AGN) stock average daily volume is
1,746,490 shares per day.
However, on last trading session of Nov 13, 2009
AGN stock traded 928,843 shares.
Also The Short Ratio for (NYSE:AGN) stock is 2.00.
On previous trading session AGN Stock closed at $59.47 per share.
Last year ALLERGAN INC (NYSE:AGN) before taxes (EBITDA) (ttm) earned $1.262B on total revenue of $4.336B.
Earnings Per Share - EPS (ttm) for AGN stock is 1.842.
Also, (NYSE:AGN) Stock Price Per Earnings ratio - P/E is 32.29.
Thus, (NYSE:AGN) Stock Price/Sales (ttm) ratio is 4.16 and Price/Book (mrq) ratio is 3.97.
(NYSE:AGN) Stock pays a dividend of $0.20 per share which is a yield of 0.34%.
So at this time (NYSE:AGN) Stock maintains Trailing Annual Dividend Rate at 0.20
.
StockRing Recommendations for ALLERGAN INC (NYSE:AGN) Stock are updated daily here
Allergan Inc.
2525 Dupont Drive
Irvine, CA 92612
United States - Map
Phone: 714-246-4500
Fax: 714-246-6987
Web Site: http://www.allergan.com
ALLERGAN INC (NYSE: AGN) DETAILS
ALLERGAN INC (NYSE: AGN) Index Membership: S&P 500
S&P 1500 Super Comp
ALLERGAN INC (NYSE: AGN) Sector: Healthcare
ALLERGAN INC (NYSE: AGN) Industry: Drug Manufacturers - Other
ALLERGAN INC (NYSE: AGN) Full Time Employees: 8,000
ALLERGAN INC (NYSE: AGN) BUSINESS SUMMARY
Allergan, Inc., a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatological, breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. It operates in two segments, Specialty Pharmaceuticals and Medical Devices. The Specialty Pharmaceuticals segment offers a range of pharmaceutical products, including ophthalmic products for chronic dry eye, glaucoma therapy, ocular inflammation, infection, and allergy; Botox for the therapeutic and aesthetic indications; skin care products for acne, psoriasis, and other skin care products; eyelash growth products; and urologics products. The Medical Devices segment offers a range of medical devices, such as breast implants for augmentation, revision, and reconstructive surgery; obesity intervention products, including the Lap-Band System and the BIB BioEnterics Intragastric Balloon; and facial aesthetics products. The company also offers Contigen for the treatment of urinary incontinence due to intrinsic sphincter deficiency. It sells its products to drug wholesalers, independent and chain drug stores, pharmacies, commercial optical chains, opticians, mass merchandisers, food stores, hospitals, group purchasing organizations, integrated direct hospital networks, and ambulatory surgery centers, as well as to medical practitioners, including ophthalmologists, neurologists, dermatologists, plastic and reconstructive surgeons, aesthetic specialty physicians, bariatric surgeons, pediatricians, urologists, and general practitioners. Allergan, Inc. has strategic research collaboration agreements with ExonHit Therapeutics S.A.; Spectrum Pharmaceuticals, Inc.; and Pieris. The company was founded in 1948 and is headquartered in Irvine, California.
ALLERGAN INC (NYSE: AGN) KEY EXECUTIVES, SALARIES and BONUSES
Mr. David E.I. Pyott , Age: 55
Chairman and Chief Exec. Officer Salary: $ 2.56M Bonus: $ 0
Mr. Michael Ball , Age: 51
Pres Salary: $ 1.01M Bonus: $ 0
Mr. Gavin S. Herbert , Age: 76
Founder, Chairman Emeritus and Member of Science & Technology Committee Salary: $ 57.00K Bonus: N/A
Mr. Jeffrey L. Edwards , Age: 48
Chief Financial Officer and Exec. VP of Fin. & Bus. Devel. Salary: $ 759.00K Bonus: $ 0
Mr. Douglas S. Ingram J.D., Esq., Age: 46
Chief Admin. Officer, Chief Ethics Officer, Exec. VP, Gen. Counsel and Sec. Salary: $ 828.00K Bonus: $ 521.00K
Nov 13, 2009 (Close-Up Media via COMTEX) -- SPPI -- Spectrum Pharmaceuticals, Inc., a commercial stage biotechnology company with a primary focus in oncology, and Nippon Kayaku announced an ...
IRVINE, Calif.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial-stage biotechnology company with a primary focus in oncology, today reported financial results for ...
(live-PR.com) - Reportlinker.com announces that a new market research report related to the Pharmaceutical industry is available in its catalogue. contain detailed information on pipelines by ...
Allergan (NYSE: AGN) hit a new 52-Week high of $60.25 so far today. Currently the stock is up $0.10 (0.16%) to $59.97 on 712,947 shares traded. Today's high is up $31.02 from a 52-Week Low of $28 ...
Cosmetic drugs are hot and happening even as the economy limps along--just take a gander at cosmeceuticals specialist Medici's latest numbers as proof. But not all beautifying treatments are ...
CARLSBAD, CA, Nov 10, 2009 (MARKETWIRE via COMTEX) -- WDC -- MaxLinear Inc., a leading provider of radio-frequency (RF) & mixed-signal IC solutions for broadband communications applications, today ...
Nov 10, 2009 (Datamonitor via COMTEX) -- AGN -- Caraco Pharmaceutical Laboratories, a developer of generic and private-label pharmaceuticals, has launched ketorolac tromethamine ophthalmic ...
IRVINE, Calif.--(BUSINESS WIRE)--Spectrum Pharmaceuticals, Inc. (NasdaqGM: SPPI), a commercial stage biotechnology company with a primary focus in oncology, and Nippon Kayaku today announced an ...
Ozurdex (Allergan) is now on the market and available for ophthalmologists to treat patients with retinal vascular occlusions (RVO). While the technology and treatment may be sound, there may be ...
EVP, Fin & Bus. Dev., CFO of Allergan Inc. (AGN) Jeffrey L Edwards sells 32,592 shares of AGN on 11/06/2009 at an average price of $59.27 a share. Allergan Inc. has a market cap of $18.02 billion ...
ADR Report: ADRs Close Lower With Broad Sector Weakness Wall Street Journal BA) fell 7.8% to $7.85, Aegon NV (AEG, AGN.AE) slipped 7.6% to $7.51 and Orix Corp. (IX, 8591.TO) declined 5.5% to $34.54. The process industry also closed ...
About this author: Seeking Alpha (blog) Allergan (AGN) is expected to report Q3 earnings on Thursday, October 29 before the market open with a conference call scheduled for 11am ET. ...
ING to split banking and insurance operations MarketWatch ... depending on whether its stock price is above 11.16 euros. That premium of 12% to 19% is steeper than the 10% Aegon (AMSTERDAM:NL:AGN) was assessed. ...
12/7/2008 StockRing advise: SELL 33% or 163, HOLD 47% or 237, BUY ...AGN, BUY - Allergan, Inc. (NYSE : AGN), Dec 5, 38.54, +2.12, +5.82%, 2877487. 20. AIG, HOLD - American International Group... (NYSE : AIG), Dec 5, 1.94, +0.10, +5.43%, 57956796. 21. AIV, SUPER SELL - Apartment Investment and. ...
12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ...agn, buy - allergan, inc. (nyse : agn), dec 5, 38.54, +2.12, +5.82%, 2877487. 20. aig, hold - american international group... (nyse : aig), dec 5, 1.94, +0.10, +5.43%, 57956796. 21. aiv, super sell - apartment investment and. ...
12/25/2008 stockring advise: sell 35% or 176, hold 39% or 195, buy ...agn, hold - allergan, inc. (nyse : agn), dec 24, 36.44, +0.28, +0.77%, 380869. 20. aig, hold - american international group... (nyse : aig), dec 24, 1.56, +0.01, +0.65%, 12441717. 21. aiv, hold - apartment investment and. ...
12/3/2008 stockring advise: sell 39.4% or 197, hold 50.4% or 252 ...agn, hold - allergan, inc. (nyse : agn), 4:06pm, 36.20, +1.39, +3.99%, 2520686. 20. aig, hold - american international group... (nyse : aig), 4:02pm, 2.01, +0.14, +7.49%, 96811632. 21. aiv, super sell - apartment investment and. ...
11/22/2008 stockring buy-sell-hold ratings for s&p 500 stocksagn, sell - allergan, inc. (nyse : agn), nov 20, 29.65, -4.46, -13.08%, 4701486. 20. aig, sell - american international group... (nyse : aig), nov 20, 1.44, -0.12, -7.69%, 84735864. 21. aiv, super sell - apartment investment and. ...
12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ...agn, buy - allergan, inc. (nyse : agn), dec 5, 38.54, +2.12, +5.82%, 2877487. 20. aig, hold - american international group... (nyse : aig), dec 5, 1.94, +0.10, +5.43%, 57956796. 21. aiv, super sell - apartment investment and. ...
12/7/2008 stockring advise: sell 33% or 163, hold 47% or 237, buy ...agn, buy - allergan, inc. (nyse : agn), dec 5, 38.54, +2.12, +5.82%, 2877487. 20. aig, hold - american international group... (nyse : aig), dec 5, 1.94, +0.10, +5.43%, 57956796. 21. aiv, super sell - apartment investment and. ...
12/3/2008 stockring advise: sell 39.4% or 197, hold 50.4% or 252 ...agn, hold - allergan, inc. (nyse : agn), dec 3, 36.20, +1.39, +3.99%, 2520686. 20. aig, hold - american international group... (nyse : aig), dec 3, 2.01, +0.14, +7.49%, 96811632. 21. aiv, super sell - apartment investment and. ...
Data and information is provided for informational purposes only, and is not intended
for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any
actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information
found therein.
No comments:
Post a Comment